IDXX as of Nov 7 · 12:26 ET
IDXXNasdaqIn Vitro & In Vivo Diagnostic Substances
Idexx Laboratories Inc · Brief
Next report
86 days
Feb 1 · before openest.Q4 FY26
Expected move
No implied move.
5 of 8≥ implied
- avg implied
- ±7.9%
- avg realized
- ±11.6%
Feb 3 '25±7.2%▲+11.13%×1.54
May 1 '25±6.5%▲+8.95%×1.37
Aug 4 '25±6.9%▲+27.49%×4.01
Nov 3 '25±8.5%▲+14.84%×1.75
Feb 2 '26±8.9%▼−4.60%×0.51
Q1 FY26±8.0%▼−0.03%×0.00
Q2 FY26±8.4%▲+3.57%×0.42
Q3 FY26±8.6%▲+21.85%×2.53
quarterimplied−30%0+30%realized×
Q3 FY26±8.6%▲+21.85%×2.53
Q2 FY26±8.4%▲+3.57%×0.42
Q1 FY26±8.0%▼−0.03%×0.00
Feb '26±8.9%▼−4.60%×0.51
Nov '25±8.5%▲+14.84%×1.75
Aug '25±6.9%▲+27.49%×4.01
2 older reports
May '25±6.5%▲+8.95%×1.37
Feb '25±7.2%▲+11.13%×1.54
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Feb 1 report · est.—
Linked exposure
IDXX report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.